Factors influencing post-coronary artery bypass grafting atrial fibrillation episodes

Kardiologia Polska

Volumn 71, Issue 11, 2013, Pages 1115-1120

  Mariscalco, Giovanni ^a   Musumeci, Francesco ^b   Banach, Maciej ^c  

^a University of Varese   (Italy)

^b SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^c MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ASCORBIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM; CORTICOSTEROID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INOTROPIC AGENT; MAGNESIUM; NONSTEROID ANTIINFLAMMATORY AGENT; OMEGA 3 FATTY ACID; PHOSPHATE; POTASSIUM;

ACUTE KIDNEY FAILURE; AGE; ARTIFICIAL VENTILATION; CENTRAL VENOUS PRESSURE; CEREBROVASCULAR ACCIDENT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONGESTIVE HEART FAILURE; CORONARY ARTERY BYPASS GRAFT; DIABETES MELLITUS; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; ERYTHROCYTE TRANSFUSION; FLUID BALANCE; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE FUNCTION; HEART SURGERY; HEART VENTRICLE PACING; HEREDITY; HUMAN; HYPERTENSION; INTRAAORTIC BALLOON PUMP; INTRAOPERATIVE PERIOD; ISCHEMIA; OFF PUMP CORONARY SURGERY; OXIDATIVE STRESS; PERICARDITIS; PREOPERATIVE PERIOD; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; RISK FACTOR; SYMPATHETIC FUNCTION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ATRIAL FIBRILLATION; CAUSALITY; COMORBIDITY; CORONARY ARTERY BYPASS; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; HUMANS; INFLAMMATION; POSTOPERATIVE COMPLICATIONS; RISK FACTORS;

EID: 84888230197     PISSN: 00229032     EISSN: None     Source Type: Journal    
DOI: 10.5603/KP.2013.0291     Document Type: Review

References (141)

1. Kittle CF, Crockett JE. The etiology and prevention of atrial fibrillation after mitral valvotomy. J Thorac Cardiovasc Surg, 1959; 38: 353-361.
2. Banach M, Kourliouros A, Reinhart KM et al. Postoperative atrial fibrillation: what do we really know? Curr Vasc Pharmacol, 2010; 8: 553-572.
3. Banach M, Misztal M, Goch A et al. Predictors of atrial fibrillation in patients following isolated surgeical revascularization. A meta-analysis of 9 studies with 28786 patients. Arch Med Sci, 2007; 3: 229-239.
4. Creswell LL, Schuessler RB, Rosenbloom M et al. Hazards of postoperative atrial arrhythmias. Ann Thorac Surg, 1993; 56: 539-549.
5. Mathew JP, Parks R, Savino JS et al. Atrial fibrillation following coronary artery bypass graft surgery: predictors, outcomes, and resource utilization: Multicenter Study of Perioperative Ischemia Research Group. JAMA, 1996; 276: 300-306.
6. Mathew JP, Fontes ML, Tudor IC et al. A multicenter risk index for atrial fibrillation after cardiac surgery. JAMA, 2004; 291: 1720-1729.
7. Villareal RP, Hariharan R, Liu BC et al. Postoperative atrial fibrillation and mortality after coronary artery bypass surgery. J Am Coll Cardiol, 2004; 43: 742-748.
8. Mahoney EM, Thompson TD, Veledar E et al. Cost-effectiveness of targeting patients undergoing cardiac surgery for therapy with intravenous amiodarone to prevent atrial fibrillation. J Am Coll Cardiol, 2002; 40: 737-745.
9. Levy D, Kannel WB. Postoperative atrial fibrillation and mortality: do the risks merit changes in clinical practice? J Am Coll Cardiol, 2004; 43: 749-751.
10. Mariscalco G, Engstrom KG. Atrial fibrillation after cardiac surgery: risk factors and their temporal relationship in prophylactic drug strategy decision. Int J Cardiol, 2008; 129: 354-362.
11. Mariscalco G, Klersy C, Zanobini M et al. Atrial fibrillation after isolated coronary surgery affects late survival. Circulation, 2008; 118: 1612-1618.
12. Mariscalco G, Engström KG. Postoperative atrial fibrillation is associated with late mortality after coronary surgery, but not after valvular surgery. Ann Thorac Surg, 2009; 88: 1871-1876.
13. Banach M, Goch A, Misztal M et al. Relation between postoperative mortality and atrial fibrillation before surgical revascularization-3-year follow-up. Thorac Cardiovasc Surg, 2008; 56: 20-23.
14. Ahlsson A, Fengsrud E, Bodin L et al. Postoperative atrial fibrillation in patients undergoing aortocoronary bypass surgery carries an eightfold risk of future atrial fibrillation and a doubled cardiovascular mortality. Eur J Cardiothorac Surg, 2010; 37: 1353-1359.
15. Leitch JW, Thomson D, Baird DK et al. The importance of age as a predictor of atrial fibrillation and flutter after coronary artery bypass grafting. J Thorac Cardiovasc Surg, 1990; 100: 338-342.
16. Shen J, Lall S, Zheng V et al. The persistent problem of new-onset postoperative atrial fibrillation: a single-institution experience over two decades. J Thorac Cardiovasc Surg, 2011; 141: 559-570.
17. Zacharias A, Schwann TA, Riordan CJ et al. Obesity and risk of new-onset atrial fibrillation after cardiac surgery. Circulation, 2005; 112: 3247-3255.
18. Kalavrouziotis D, Buth KJ, Ali IS. The impact of new-onset atrial fibrillation on in-hospital mortality following cardiac surgery. Chest, 2007; 131: 833-839.
19. Magee MJ, Herbert MA, Dewey TM et al. Atrial fibrillation after coronary artery bypass grafting surgery: development of a predictive risk algorithm. Ann Thorac Surg, 2007; 83: 1707-1712.
20. Hravnak M, Hoffman LA, Saul MI et al. Resource utilization related to atrial fibrillation after coronary artery bypass grafting. Crit Care Med, 2002; 30: 330-337.
21. Almassi GH, Schowalter T, Nicolosi AC et al. Atrial fibrillation after cardiac surgery: a major morbid event? Ann Surg, 1997; 226: 501-511.
22. Auer J,Weber T, Berent R et al. Postoperative atrial fibrillation independently predicts prolongation of hospital stay after cardiac surgery. J Cardiovasc Surg, 2005; 46: 583-588.
23. Aranki SF, Shaw DP, Adams DH et al. Predictors of atrial fibrillation after coronary artery surgery. Current trends and impact on hospital resources. Circulation, 1996; 94: 390-397.
24. Zaman AG, Archbold RA, Helft G et al. Atrial fibrillation after coronary artery bypass surgery: a model for preoperative risk stratification. Circulation, 2000; 101: 1403-1408.
25. Cox JL. A perspective of postoperative atrial fibrillation in cardiac operations. Ann Thorac Surg, 1993; 56: 405-409.
26. Cox JL, Ad N, Palazzo T. Impact of the maze procedure on the stroke rate in patients with atrial fibrillation. J Thorac Cardiovasc Surg, 1999; 118: 833-840.
27. Cox JL, Schuessler RB, D'Agostino HJ, Jr. et al. The surgical treatment of atrial fibrillation. III. Development of a definitive surgical procedure. J Thorac Cardiovasc Surg, 1991; 101: 569-583.
28. Cox JL. A perspective on postoperative atrial fibrillation. Semin Thorac Cardiovasc Surg, 1999; 11: 299-302.
29. Haissaguerre M, Jais P, Shah DC et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med, 1998; 339: 659-666.
30. Moe GK. A conceptual model of atrial fibrillation. J Electrocardiol, 1968; 1: 145-146.
31. Jais P, Haissaguerre M, Shah DC et al. A focal source of atrial fibrillation treated by discrete radiofrequency ablation. Circulation, 1997; 95: 572-576.
32. Fuller JA, Adams GG, Buxton B. Atrial fibrillation after coronary artery bypass grafting. Is it a disorder of the elderly? J Thorac Cardiovasc Surg, 1989; 97: 821-825.
33. Benjamin EJ, Levy D, Vaziri SM et al. Independent risk factors for atrial fibrillation in a population-based cohort: the Framingham heart study. JAMA, 1994; 271: 840-844.
34. Spach MS, Dolber PC. Relating extracellular potentials and their derivatives to anisotropic propagation at a microscopic level in human cardiac muscle. Evidence for electrical uncoupling of side-to-side fiber connections with increasing age. Circ Res, 1986; 58: 356-371.
35. Barasch E, Gottdiener JS, Aurigemma G et al. Association between elevated fibrosis markers and heart failure in the elderly/clinical perspective. Circulation Heart Fail, 2009; 2: 303-310.
36. Li D, Fareh S, Leung TK, Nattel S. Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort. Circulation, 1999; 100: 87-95.
37. Kopecky SL, Gersh BJ, McGoon MD et al. The natural history of lone atrial fibrillation: a population-based study over three decades. N Engl J Med, 1987; 317: 669-674.
38. Cooke J, Creager M, Osmundson P et al. Sex differences in control of cutaneous blood flow. Circulation, 1990; 82: 1607-1615.
39. Schotten U, Verheule S, Kirchhof P et al. Pathophysiological mechanisms of atrial fibrillation: a translational appraisal. Physiol Rev, 2011; 91: 265-325.
40. Sun X, Boyce SW, Hill PC et al. Association of body mass index with new-onset atrial fibrillation after coronary artery bypass grafting operations. Ann Thorac Surg, 2011; 91: 1852-1858.
41. Bramer S, van Straten AH, Soliman Hamad MA et al. Body mass index predicts new-onset atrial fibrillation after cardiac surgery. Eur J Cardiothorac Surg, 2011; 40: 1185-1190.
42. McLenachan JM, Dargie HJ. Ventricular arrhythmias in hypertensive left ventricular hypertrophy. Relationship to coronary artery disease, left ventricular dysfunction, and myocardial fibrosis. Am J Hypertension, 1990; 3: 735-740.
43. Peters NS, Green CR, Poole-Wilson PA et al. Reduced content of connexin43 gap junctions in ventricular myocardium from hypertrophied and ischemic human hearts. Circulation, 1993; 88: 864-875.
44. L'Allier PL, Ducharme A, Keller P-F et al. Angiotensin converting enzyme inhibition in hypertensive patients is associated with a reduction in the occurrence of atrial fibrillation. J Am Coll Cardiol, 2004; 44: 159-164.
45. Topol EJ, Traill TA, Fortuin NJ. Hypertensive hypertrophic cardiomyopathy of the elderly. N Engl J Med, 1985; 312: 277-283.
46. Kuralay E, Cingöz F, Kiliç S et al. Supraventricular tachyarrhythmia prophylaxis after coronary artery surgery in chronic obstructive pulmonary disease patients (early amiodarone prophylaxis trial). Eur J Cardiothorac Surg, 2004; 25: 224-230.
47. Crosby LH, Pifalo WB, Woll KR et al. Risk factors for atrial fibrillation after coronary artery bypass grafting. Am J Cardiol, 1990; 66: 1520-1522.
48. Rubin DA, Nieminski KE, Reed GE et al. Predictors, prevention, and long-term prognosis of atrial fibrillation after coronary artery bypass graft operations. J Thorac Cardiovasc Surg, 1987; 94: 331-335.
49. Hurt C, Coisne A, Modine T et al. Contrasting effects of diabetes and metabolic syndrome on post-operative atrial fibrillation and in-hospital outcome after cardiac surgery. Int J Cardiol, 2012; doi: 10.1016/j.ijcard.2012.11.034.
50. Kannel WB, Abbott RD, Savage DD et al. Epidemiologic features of chronic atrial fibrillation: the Framingham study. N Engl J Med, 1982; 306: 1018-1022.
51. Movahed MR, Hashemzadeh M, Jamal MM. Diabetes mellitus is a strong, independent risk for atrial fibrillation and flutter in addition to other cardiovascular disease. Int J Cardiol, 2005; 105: 315-318.
52. Cummings JE, Gill I, Akhrass R et al. Preservation of the anterior fat pad paradoxically decreases the incidence of postoperative atrial fibrillation in humans. J Am Coll Cardiol, 2004; 43: 994-1000.
53. Mariscalco G, Engström KG. Are current smokers paradoxically protected against atrial fibrillation after cardiac surgery? Nicotine Tob Res, 2009; 11: 58-63.
54. Ad N, Snir E, Vidne BA et al. Potential preoperative markers for the risk of developing atrial fibrillation after cardiac surgery. Semin Thorac Cardiovasc Surg, 1999; 11: 308-313.
55. Ad N, Snir E, Vidne BA et al. Histologic atrial myolysis is associated with atrial fibrillation after cardiac operation. Ann Thorac Surg, 2001; 72: 688-693.
56. Ak K, Akgun S, Tecimer T et al. Determination of histopathologic risk factors for postoperative atrial fibrillation in cardiac surgery. Ann Thorac Surg, 2005; 79: 1970-1975.
57. Goette A, Juenemann G, Peters B et al. Determinants and consequences of atrial fibrosis in patients undergoing open heart surgery. Cardiovasc Res, 2002; 54: 390-396.
58. Mariscalco G, Engström KG, Ferrarese S et al. Relationship between atrial histopathology and atrial fibrillation after coronary bypass surgery. J Thorac Cardiovasc Surg, 2006; 131: 1364-1372.
59. Spach MS, Dolber PC. Relating extracellular potentials and their derivatives to anisotropic propagation at a microscopic level in human cardiac muscle. Evidence for electrical uncoupling of side-to-side fiber connections with increasing age. Circ Res, 1986; 58: 356-371.
60. McLenachan JM, Dargie HJ. Ventricular arrhythmias in hypertensive left ventricular hypertrophy. Relationship to coronary artery disease, left ventricular dysfunction, and myocardial fibrosis. Am J Hypertens, 1990; 3: 35-740.
61. Dupont E, Ko Y, Rothery S et al. The gap-junctional protein connexin40 is elevated in patients susceptible to postoperative atrial fibrillation. Circulation, 2001; 103: 842-849.
62. Wilhelm M, Kirste W, Kuly S et al. Atrial distribution of connexin 40 and 43 in patients with intermittent, persistent, and postoperative atrial fibrillation. Heart Lung Circ, 2006; 15: 30-37.
63. Nao T, Ohkusa T, Hisamatsu Y et al. Comparison of expression of connexin in right atrial myocardium in patients with chronic atrial fibrillation versus those in sinus rhythm. Am J Cardiol, 2003; 91: 678-683.
64. Aimé-Sempé C, Folliguet T, Rücker-Martin C et al. Myocardial cell death in fibrillating and dilated human right atria. J Am Coll Cardiol, 1999; 34: 1577-1586.
65. Verheule S, Wilson E, Everett TIV et al. Alterations in atrial electrophysiology and tissue structure in a canine model of chronic atrial dilatation due to mitral regurgitation. Circulation, 2003; 107: 2615-2622.
66. Steinberg JS, Zelenkofske S, Wong SC et al. Value of the P-wave signal-averaged ECG for predicting atrial fibrillation after cardiac surgery. Circulation, 1993; 88: 2618-2622.
67. Zaman AG, Alamgir F, Richens T et al. The role of signal averaged P wave duration and serum magnesium as a combined predictor of atrial fibrillation after elective coronary artery bypass surgery. Heart, 1997; 77: 527-531.
68. Hayashida N, Shojima T, Yokokura Y et al. P-wave signal-averaged electrocardiogram for predicting atrial arrhythmia after cardiac surgery. Ann Thorac Surg, 2005; 79: 859-864.
69. Buxton AE, Josephson ME. The role of P wave duration as a predictor of postoperative atrial arrhythmias. Chest, 1981; 80: 68-73.
70. Faggiano P, D'Aloia A, Zanelli E et al. Contribution of left atrial pressure and dimension to signal-averaged P-wave duration in patients with chronic congestive heart failure. Am J Cardiol, 1997; 79: 219-222.
71. Leung JM, Bellows WH, Schiller NB. Impairment of left atrial function predicts post-operative atrial fibrillation after coronary artery bypass graft surgery. Eur Heart J, 2004; 25: 1836-1844.
72. Benedetto U, Melina G, Roscitano A et al. Clinical utility of tissue Doppler imaging in prediction of atrial fibrillation after coronary artery bypass grafting. Ann Thorac Surg, 2007; 83: 83-88.
73. Roshanali F, Mandegar MH, Yousefinia MA et al. Prediction of atrial fibrillation via atrial electromechanical interval after coronary artery bypass grafting. Circulation, 2007; 116: 2012-2017.
74. Gaudino M, Andreotti F, Zamparelli R et al. The -174G/C interleukin-6 polymorphism influences postoperative interleukin-6 levels and postoperative atrial fibrillation. Is atrial fibrillation an inflammatory complication? Circulation, 2003; 108: 195-199.
75. Sinno H, Derakhchan K, Libersan D et al. Atrial ischemia promotes atrial fibrillation in dogs. Circulation, 2003; 107: 1930-1936.
76. Hakala T, Pitkanen O, Hartikainen J. Cardioplegic arrest does not increase the risk of atrial fibrillation after coronary artery bypass surgery. Eur J Cardiothrorac Surg, 2005; 25: 415-418.
77. Tselentakis EV, Woodford E, Chandy J et al. Inflammation effects on the electrical properties of atrial tissue and inducibility of postoperative atrial fibrillation. J Surg Res, 2006; 135: 68-75.
78. Chello M, Patti G, Candura D et al. Effects of atorvastatin on systemic inflammatory response after coronary bypass surgery. Crit Care Med, 2006; 34: 660-667.
79. Bruins P, te Velthuis H, Yazdanbakhsh AP et al. Activation of the complement system during and after cardiopulmonary bypass surgery: postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia. Circulation, 1997; 96: 3542-3548.
80. Chung MK, Martin DO, Sprecher D et al. C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation, 2001; 104: 2886-2891.
81. Aviles RJ, Martin DO, Apperson-Hansen C et al. Inflammation as a Risk Factor for Atrial Fibrillation. Circulation, 2003; 108: 3006-3010.
82. Abdelhadi RH, Gurm HS, Van Wagoner DR et al. Relation of an exaggerated rise in white blood cells after coronary bypass or cardiac valve surgery to development of atrial fibrillation postoperatively. Am J Cardiol, 2004; 93: 1176-1178.
83. Anselmi A, Possati G, Gaudino M. Postoperative inflammatory reaction and atrial fibrillation: simple correlation or causation? Ann Thorac Surg, 2009; 88: 326-333.
84. Ishii Y, Schuessler RB, Gaynor SL et al. Inflammation of atrium after cardiac surgery is associated with inhomogeneity of atrial conduction and atrial fibrillation. Circulation, 2005; 111: 2881-2888.
85. Frustaci A, Chimenti C, Bellocci F et al. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation, 1997; 96: 1180-1184.
86. Chen M-C, Chang J-P, Liu W-H et al. Increased inflammatory cell infiltration in the atrial myocardium of patients with atrial fibrillation. Am J Cardiol, 2008; 102: 861-865.
87. Wijeysundera DN, Beattie WS, Djaiani G et al. Off-pump coronary artery surgery for reducing mortality and morbidity: meta-analysis of randomized and observational studies. J Am Coll Cardiol, 2005; 46: 872-882.
88. Moller CH, Penninga L, Wetterslev J et al. Clinical outcomes in randomized trials of off- vs on-pump coronary artery bypass surgery: systematic review with meta-analyses and trial sequential analyses. Eur Heart J, 2008; 29: 2601-2616.
89. Ho KM, Tan JA. Benefits and risks of corticosteroid prophylaxis in adult cardiac surgery: a dose-response meta-analysis. Circulation, 2009; 119: 1853-1866.
90. Ruffin RT, Kluger J, Baker WL et al. Association between perioperative NSAID use and post-cardiothoracic surgery atrial fibrillation, blood transfusions, and cardiovascular outcomes: a nested cohort study from the AF Suppression Trials (AFIST) I, II and III. Curr Med Res Opin, 2008; 24: 1131-1136.
91. Wright DG, Lefer DJ. Statin mediated protection of the ischemic myocardium. Vascul Pharmacol, 2005; 42: 265-270.
92. Fang WT, Li HJ, Zhang H et al. The role of statin therapy in the prevention of atrial fibrillation: a meta-analysis of randomized controlled trials. Br J Clin Pharmacol, 2012; 74: 744-756.
93. Mariscalco G, Lorusso R, Klersy C et al. Observational study on the beneficial effect of preoperative statins in reducing atrial fibrillation after coronary surgery. Ann Thorac Surg, 2007; 84: 1158-1164.
94. Mariscalco G, Sarzi Braga S, Banach M et al. Preoperative n-3 polyunsatured fatty acids are associated with a decrease in the incidence of early atrial fibrillation following cardiac surgery. Angiology, 2010; 61: 643-650.
95. Kalman JM, Munawar M, Howes LG et al. Atrial fibrillation after coronary artery bypass grafting is associated with sympathetic activation. Ann Thorac Surg, 1995; 60: 1709-1715.
96. Workman A. Cardiac adrenergic control and atrial fibrillation. Naunyn-Schmiedeberg's Arch Pharmacol, 2010; 381: 235-249.
97. Hoeldtke RD, Cilmi KM. Effects of aging on catecholamine metabolism. J Clin Endocrinol Metab, 1985; 60: 479-84.
98. Dimmer C, Tavernier R, Gjorgov N et al. Variations of autonomic tone preceding onset of atrial fibrillation after coronary artery bypass grafting. Am J Cardiol, 1998; 82: 22-25.
99. Amar D, Zhang H, Miodownik S et al. Competing autonomic mechanisms precede the onset of postoperative atrial fibrillation. J Am Coll Cardiol, 2003; 42: 1262-1268.
100. Hogue CW, Domitrovich PP, Stein PK et al. RR interval dynamics before atrial fibrillation in patients after coronary artery bypass graft surgery. Circulation, 1998; 98: 429-434.
101. Waldo AL. Mechanisms of atrial fibrillation, atrial flutter, and ectopic atrial tachycardia-a brief review. Circulation, 1987; 75: III37-III40.
102. Melo J, Voigt P, Sonmez B et al. Ventral cardiac denervation reduces the incidence of atrial fibrillation after coronary artery bypass grafting. J Thorac Cardiovasc Surg, 2004; 127: 511-516.
103. Burgess DC, Kilborn MJ, Keech AC. Interventions for prevention of postoperative atrial fibrillation and its complications after cardiac surgery: a meta-analysis. Eur Heart J, 2006; 27: 2846-2857.
104. Crystal E, Connolly SJ, Sleik K et al. Interventions on prevention of postoperative atrial fibrillation in patients undergoing heart surgery: a meta-analysis. Circulation, 2002; 106: 75-80.
105. Lamb RK, Prabhakar G, Thorpe JAC et al. The use of atenolol in the prevention of supraventricular arrhythmias following coronary artery surgery. Eur Heart J, 1988; 9: 32-36.
106. White HD, Antman EM, Glynn MA et al. Efficacy and safety of timolol for prevention of supraventricular tachyarrhythmias after coronary artery bypass surgery. Circulation, 1984; 70: 479-484.
107. Halonen J, Hakala T, Auvinen T et al. Intravenous administration of metoprolol is more effective than oral administration in prevention of atrial fibrillation after cardiac surgery. Circulation, 2006; 114 (suppl. I): I-1-I-4.
108. Ferguson TB Jr, Coombs LP, Peterson ED. Society of Thoracic Surgeons National Adult Cardiac Surgery Database. Pre-operative B-blocker use and mortality and morbidity following CABG surgery in North America. JAMA, 2002; 287: 2221-2227.
109. Dunning J, Treasure T, Versteegh M et al.; on behalf of the EACTS Audit Guidelines Committee. Guidelines for the prevention and management of de novo atrial fibrillation after cardiac and thoracic surgery. Eur J Cardiothorac Surg, 2006; 30: 852-872.
110. Workman AJ, Pau D, Redpath CJ et al. Postoperative atrial fibrillation is influenced by beta-blocker therapy but not by preoperative atrial cellular electrophysiology. J Cardiovasc Electrophysiol, 2006; 17: 1230-1238.
111. Fleming GA, Murray KT, Yu C et al. Milrinone use is associated with postoperative atrial fibrillation after cardiac surgery. Circulation, 2008; 118: 1619-1625.
112. Feneck RO, Sherry KM, Withington PS et al. Comparison of the hemodynamic effects of milrinone with dobutamine in patients after cardiac surgery. J Cardiothorac Vasc Anesth, 2001; 15: 306-315.
113. Argalious M, Motta P, Khandwala F et al. 'Renal dose' dopamine is associated with the risk of new-onset atrial fibrillation after cardiac surgery. Crit Care Med, 2005; 33: 1327-1332.
114. Salaria V, Mehta NJ, Abdul-Aziz S et al. Role of postoperative vasopressor use in occurrence of atrial fibrillation after coronary artery bypass grafting. Am J Cardiol, 2005; 95: 247-249.
115. Epstein FH, McCord JM. Oxygen-derived free radicals in postischemic tissue injury. New Engl J Med, 1985; 312: 159-163.
116. Carmeliet E. Cardiac ionic currents and acute ischemia: from channels to arrhythmias. Physiol Rev, 1999; 79: 917-1017.
117. Clermont G, Vergely C, Jazayeri S et al. Systemic free radical activation is a major event involved in myocardial oxidative stress related to cardiopulmonary bypass. Anesthesiology, 2002; 96: 80-87.
118. Ramlawi B, Otu H, Mieno S et al. Oxidative stress and atrial fibrillation after cardiac surgery: a case-control study. Ann Thorac Surg, 2007; 84: 1166-1173.
119. Eslami M, Badkoubeh RS, Mousavi M et al. Oral ascorbic acid in combination with beta-blockers is more effective than beta-blockers alone in the prevention of atrial fibrillation after coronary artery bypass grafting. Tex Heart Inst J, 2007; 34: 268-274.
120. Ozaydin M, Peker O, Erdogan D et al. N-acetylcysteine for the prevention of postoperative atrial fibrillation: a prospective, randomized, placebo-controlled pilot study. Eur Heart J, 2008; 29: 625-631.
121. Tossios P, Bloch W, Huebner A et al. N-acetylcysteine prevents reactive oxygen species-mediated myocardial stress in patients undergoing cardiac surgery: results of a randomized, double-blind, placebo-controlled clinical trial. J Thoracic Cardiovasc Surg, 2003; 126: 1513-1520.
122. Baker WL, Anglade MW, Baker EL et al. Use of N-acetylcysteine to reduce post-cardiothoracic surgery complications: a meta-analysis. Eur J Cardiothorac Surg, 2009; 35: 521-527.
123. Liakopoulos OJ, Choi Y-H, Kuhn EW et al. Statins for prevention of atrial fibrillation after cardiac surgery: a systematic literature review. J Thorac Cardiovasc Surg, 2009; 138: 678-686.
124. Banach M, Goch JH, Ugurlucan M et al. Statins in the prevention of postoperative atrial fibrillation: is there really no effect? Am Heart J, 2008; 155: e53.
125. Banach M, Rysz J, Drozdz JA et al. Risk factors of atrial fibrillation following coronary artery bypass grafting: a preliminary report. Circ J, 2006; 70: 438-441.
126. Banach M, Mikhailidis DP, Kjeldsen SE, Rysz J. Time for new indications for statins? Med Sci Monit, 2009; 15: MS1-MS5.
127. Bielecka-Dabrowa A, Mikhailidis DP, Jones L et al. The meaning of hypokalemia in heart failure. Int J Cardiol, 2012; 158: 12-17.
128. Polderman KH, Girbes AR. Severe electrolyte disorders following cardiac surgery: a prospective controlled observational study. Crit Care, 2004; 8: R459-R466.
129. Hazelrigg SR, Boley TM, Cetindag IB et al. The efficacy of supplemental magnesium in reducing atrial fibrillation after coronary artery bypass grafting. Ann Thorac Surg, 2004; 77: 824-830.
130. Fanning WJ, Thomas CS, Roach A et al. Prophylaxis of atrial fibrillation with magnesium sulphate after coronary artery bypass grafting. Ann Thorac Surg, 1991; 52: 529-533.
131. Mariscalco G, Cederlund B, Engström KG. The clinical noncompliance of oral sotalol/magnesium for prophylactic treatment of atrial fibrillation after coronary artery bypass grafting. J Card Surg, 2007; 22: 281-286.
132. Frost L, Jacobsen CJ, Christiansen EH et al. Hemodynamic predictors of atrial fibrillation or flutter after coronary artery bypass grafting. Acta Anaesthesiol Scand, 1995; 39: 690-697.
133. Koch CG, Li L, Van Wagoner DR et al. Red cell transfusion is associated with an increased risk for postoperative atrial fibrillation. Ann Thorac Surg, 2006; 82: 1747-1757.
134. Fransen E, Maessen J, Dentener M et al. Impact of blood transfusions on inflammatory mediator release in patients undergoing cardiac surgery. Chest, 1999; 116: 1233-1239.
135. Fransen E, Maessen J, Dentener M et al. Systemic inflammation present in patients undergoing CABG without extracorporeal circulation. Chest, 1998; 113: 1290-1295.
136. Bissinger A, Grycewicz T, Grabowicz W, Lubinski A. The effect of diabetic autonomic neuropathy on P-wave duration, dispersion and atrial fibrillation. Arch Med Sci, 2011; 7: 806-812.
137. Aronow WS, Banach M. Atrial fibrillation: the new epidemic of the ageing world. J Atrial Fibrillation, 2009; 1: 337-361.
138. Wu X, Wang C, Zhang C et al. Computed tomography for detecting left atrial thrombus: a meta-analysis. Arch Med Sci, 2012; 8: 943-951.
139. Banach M, Goch A, Misztal M et al. Predictors of paroxysmal atrial fibrillation in patients undergoing aortic valve replacement. J Thorac Cardiovasc Surg, 2007; 134: 1569-1576.
140. Lin Q, Jia L, Sun Y. A pilot study of circulating PPAR-gamma receptor protein in elderly patients with atrial fibrillation. Arch Med Sci, 2012; 8: 471-476.
141. Bilotta F, Lauretta MP, Borozdina A et al. Postoperative delirium: Risk factors, diagnosis and perioperative care. Minerva Anestesiol, 2013; 79: 1066-1076.